Scientists find surprising risks for COVID-19 infection
In a study from Charles University, scientists examined risk factors and protections against contracting COVID-19, and also for suffering from severe COVID.
They found several...
These drugs linked to post-COVID dementia in older people
In a study from Northwell Health in Glen Oaks, scientists found pre-COVID-19 psychotropic medication use is associated with higher risk for incident dementia following...
COVID or the common cold? What to do if you have symptoms this Christmas
There’s a lot to be jolly about this Christmas. COVID has been significantly, although not completely, “defanged”, thanks to vaccines and treatments.
Christmas dos, nativity...
COVID-19 booster helps you get longer-lasting antibodies
In a study from the University of Virginia, scientists found the benefits of a COVID-19 booster.
The new findings shed light on how mRNA boosters—both...
Addicted to chilli? Here’s how it might help us regain our sense of taste...
The news of a hot chilli sauce shortages earlier this year – due to high temperatures and drought in agricultural regions – prompted warnings...
This readily available, inexpensive drug may help treat COVID-19
A recent study from the University of California Los Angeles found that an inexpensive, readily available amino acid might limit the effects of COVID-19.
It...
COVID-19 vaccination could protect people with blood cancer
In a study from the Medical Center-University of Freiburg, scientists found COVID-19 vaccination could protect people with blood cancer.
People suffering from blood cancer often...
Heart inflammation from COVID boosters is rare, but risk highest in teen boys, young...
In a study from Hadassah Ein Karem Medical Center, scientists found the risk of developing myocarditis – an inflammation of the heart muscle –...
Blood clot risk remains high nearly a year after COVID-19
scientists found people who got COVID-19 had a higher risk of dangerous blood clots close to a year later.
This drug can help COVID-19 patients recover faster
In a study from the University of Oxford, scientists found molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce...